Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d6f7b87f378a1cda6e41aa6e2e7b24df |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0019 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-183 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-22 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K51-088 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K51-083 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K51-121 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K51-08 |
filingDate |
2018-09-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate |
2022-07-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_72d3948599affe1376cf7903acd640e2 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1de1612ca4f4a7a6869b65dc3d126c0f http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_50c7533b11cad52cf30c78bcda0b98f9 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6ff3ba8f25b5f2ec94374e9ec772ab08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6df389d6e3cb3a8d8446835b083ce103 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_87be8ff330f2a83eac1a1063977bc41b http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_dd1fd4a025d8f96f9d0d521cb831dd77 |
publicationDate |
2022-07-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
AU-2018433575-B2 |
titleOfInvention |
Stable, concentrated radionuclide complex solutions |
abstract |
The present invention relates to radionuclide complex solutions of high concentration and of high chemical stability, that allows their use as drug product for diagnostic and/or therapeutic purposes. The stability of the drug product is achieved by at least one stabilizer against radiolytic degradation. The use of two stabilizers introduced during the manufacturing process at different stages was found to be of particular advantage. |
priorityDate |
2018-07-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |